DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call
...skin cancer (NMSC) in chronically immunosuppressed solid organ transplant recipients (SOTRs). In addition, DUSA is supporting research related to oral leukoplakia
in collaboration with National Institutes of Health (NIH). DUSA is based in Wilmington, Mass. Please visit our Web site at www.dusapharma.com .
Smokeless Tobacco: Not a Harmless Substitute
risks such as increased blood pressure and heart rate, increasing the risk
of heart attacks.
"Of smokeless tobacco users, 40 to 60 percent exhibit leukoplakia
white patch) in the area where the quid (tobacco) is held, usually within a
few months of beginning regular use," said Dr. Terry. "Leukoplakia is
Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
...advanced stage of developing INGN 234, a mouthwash designed to deliver the p53 tumor suppressor for the prevention of a pre-cancerous condition called leukoplakia
as well as oral cancer. David G. Nance, Chief Executive Officer of Introgen was understandably pleased with the lucrative agreement.
We believe th...
Chromosomes to predict oral cancer
...earch for an average of 8.5 years, found that oral leukoplakia
with the normal number of chromosomes — 46 — were ...y to develop into cancer. Of the 103 patients with leukoplakia
with normal DNA content, only three developed canc...However, if the number of chromosomes found in the leukoplakia
cells is doubled, cancer becomes more likely, the ...
is adherent white plaques or patches on the mucous membranes of the oral cavity, including the tongue. The clinical appearance is highly variable. Leukoplakia
is not a specific disease entity, but is diagnosis of... Leukoplakia
— Comprehensive overview covers symptoms an...